Tag: Analysts

Browse our exclusive articles!

Guardforce AI Co. Limited (GFAI) Shows Promising Growth, Analysts Target $14.00

Guardforce AI Co. Limited (GFAI) shows promising growth and a target price of $14.00/share. Get analysis and insights on this potential investment.

One Model Raises $41M in Funding to Expand AI-Powered People Analytics Platform

One Model secures $41M in funding, enhancing AI-powered people analytics platform. Expand your workforce strategies with tailored content and actionable forecasts.

Amazon Crushes Earnings Expectations, Stock Soars 9%

Amazon crushes earnings expectations, surges 9%: Impressive Q2 results and positive outlook propel stock higher. Analysts praise e-commerce and AWS strength.

Apple’s Quarterly iPhone Sales Dip Amid Slow Economy, Focus Shifts to AI Augmentation for Future Growth

Discover why Apple's decline in iPhone sales, coupled with the anticipation of a new model, highlights the need for the company to leverage artificial intelligence (AI) for future growth.

Guardforce AI Co. Limited (NASDAQ: GFAI) Surges 54.64% from 52-Week Low, 65.62% YTD Rise: What’s Your Next Move?

Guardforce AI Co. (NASDAQ: GFAI) shows impressive gains of 54.64%, prompting investors to consider their next move. Find out the latest analysis and trends.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img